The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients

This randomized controlled trial examined the effects of Coenzyme Q10 (CoQ10) supplementation on inflammatory and endothelial dysfunction markers in overweight and obese women with Polycystic Ovary Syndrome (PCOS). Over 8 weeks, CoQ10 significantly reduced levels of TNF-α, hs-CRP, IL-6, VCAM-1, and E-selectin, indicating improved inflammatory status and vascular function, although